A California-based owner of a pharmaceutical owner pleads guilty to an illicit scheme involving Injectable Stem Cell products. John W. Kosolcharoen was hauled in on charges that his dodgy drugs breached the Federal Food, Drug, and Cosmetic Act and also caused multiple hospitalizations. “Unapproved stem cell treatments not only endanger public health but also exploit the hopes of patients who seek relief from the most serious of diseases,” said Principal Deputy Assistant Attorney General Brian Boynton, head of the Justice Department’s Civil Division. According to the FDA breach, the Orange Coun…